1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostaglandin E2 Receptor EP4 Subtype Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 E-7046
1.4.3 ER-886046
1.4.4 grapiprant
1.4.5 KAG-308
1.4.6 ONO-4232
1.4.7 Others
1.5 Market by Application
1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2021-2026
1.5.2 Breast Cancer
1.5.3 Allergies
1.5.4 Chronic Pain
1.5.5 Acute Pain
1.5.6 Lung Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Prostaglandin E2 Receptor EP4 Subtype Market
1.8.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Prostaglandin E2 Receptor EP4 Subtype Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Prostaglandin E2 Receptor EP4 Subtype Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Prostaglandin E2 Receptor EP4 Subtype Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share by Region (2015-2020)
3.2 Global Prostaglandin E2 Receptor EP4 Subtype Sales Revenue Market Share by Region (2015-2020)
3.3 North America Prostaglandin E2 Receptor EP4 Subtype Sales Volume
3.3.1 North America Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.3.2 North America Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume
3.4.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.5.1 Europe Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.6.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.7.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.8.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.9.1 Africa Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.10.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.11.1 South America Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.11.2 South America Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Sales Volume (2015-2020)
3.12.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Volume Market Share by Type (2015-2020)
14.2 Global Prostaglandin E2 Receptor EP4 Subtype Sales Revenue Market Share by Type (2015-2020)
14.3 Global Prostaglandin E2 Receptor EP4 Subtype Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Volume by Application (2015-2020)
15.2 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Prostaglandin E2 Receptor EP4 Subtype Business
16.1 Eisai Co Ltd
16.1.1 Eisai Co Ltd Company Profile
16.1.2 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Ono Pharmaceutical Co Ltd
16.2.1 Ono Pharmaceutical Co Ltd Company Profile
16.2.2 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.2.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Eli Lilly and Co
16.3.1 Eli Lilly and Co Company Profile
16.3.2 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.3.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Kaken Pharmaceutical Co Ltd
16.4.1 Kaken Pharmaceutical Co Ltd Company Profile
16.4.2 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.4.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Rottapharm Biotech Srl
16.5.1 Rottapharm Biotech Srl Company Profile
16.5.2 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.5.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 RaQualia Pharma Inc
16.6.1 RaQualia Pharma Inc Company Profile
16.6.2 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Specification
16.6.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Prostaglandin E2 Receptor EP4 Subtype Manufacturing Cost Analysis
17.1 Prostaglandin E2 Receptor EP4 Subtype Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Prostaglandin E2 Receptor EP4 Subtype
17.4 Prostaglandin E2 Receptor EP4 Subtype Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Prostaglandin E2 Receptor EP4 Subtype Distributors List
18.3 Prostaglandin E2 Receptor EP4 Subtype Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype (2021-2026)
20.2 Global Forecasted Revenue of Prostaglandin E2 Receptor EP4 Subtype (2021-2026)
20.3 Global Forecasted Price of Prostaglandin E2 Receptor EP4 Subtype (2015-2026)
20.4 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype by Region (2021-2026)
20.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.3 Europe Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.7 Africa Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.9 South America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.2 East Asia Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.3 Europe Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Countriy
21.4 South Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.5 Southeast Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.6 Middle East Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.7 Africa Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.8 Oceania Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.9 South America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
21.10 Rest of the world Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer